Clinical trials
Phase 1/2 Recurrence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 9 |
| Terminated | 7 |
| Recruiting | 5 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Hoffmann-La Roche | 2 |
| Kite, A Gilead Company | 2 |
| Therapeutic Advances in Childhood Leukemia Consortium | 2 |
| University Health Network, Toronto | 2 |
| Aegera Therapeutics | 1 |
| Allogene Therapeutics | 1 |
| Amgen | 1 |
| Amgen Research (Munich) GmbH | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 39 |
| Multiple Myeloma | 8 |
| Neoplasms | 8 |
| Leukemia | 6 |
| Central Nervous System Neoplasms | 5 |
| Lymphoma | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Breast Neoplasms | 4 |
| Glioma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.